TITLE:
Study Comparing Conversion to Sirolimus vs. Continued Use of Calcineurin Inhibitors in Kidney Transplant Recipients

CONDITION:
Renal Transplantation

INTERVENTION:
Sirolimus

SUMMARY:

      The purpose of this study is to determine the effect of conversion from calcineurin
      inhibitor to sirolimus based therapy on renal function.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 13 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Age greater than or equal to 13 years.

          -  Receiving CsA or tacrolimus from the time of transplantation or within 2 weeks
             thereafter

          -  Patients with a functioning allograft and a Nankivell GFR greater than or equal to 20
             mL/min, within 2 weeks before randomization

        Exclusion Criteria:

          -  Biopsy-confirmed acute rejection within 12 weeks before randomization, that was
             determined to require antirejection treatment

          -  Patients in whom kidney-pancreas or other multiple organ transplants have been
             performed
      
